期刊文献+

盐酸西布曲明在中国志愿者体内的药代动力学(英文) 被引量:3

Pharmacokinetics of sibutramine hydrochloride in Chinese healthy volunteers
下载PDF
导出
摘要 目的 研究西布曲明主要药理活性代谢产物N 去二甲基西布曲明 (BTS 5 4 5 0 5 )在中国志愿者体内的药代动力学。方法  2 0名健康中国志愿者采用随机交叉自身对照的方式 ,单剂量po盐酸西布曲明胶囊 2 0mg。给药后 ,连续采集血样至 72h。分离得到的血浆 ,采用高效液相色谱 电喷雾 二级质谱分析BTS 5 4 5 0 5的血药浓度。结果 国产和进口胶囊剂的体内药代动力学参数AUC0 t,AUC0 ∞ ,Cmax,Tmax,T1 2 ,Kelm 和MRT均与文献报道相似。 Aim To evaluate the pharmacokinetic profiles of the pharmacologically active primary amine metabolite of sibutramine, N-di-desmethyl sibutramine (BTS 54505) in Chinese origin. Methods According to a randomized cross-over design,a single oral dose of 20 mg of sibutramine hydrochloride capsule was given to 20 healthy Chinese young volunteers. After dosing, serial blood samples were collected for a period of 72 h. BTS 54505 concentration in plasma was analyzed by high-performance liquid chromatography-e...
出处 《药学学报》 CAS CSCD 北大核心 2003年第11期850-853,共4页 Acta Pharmaceutica Sinica
关键词 西布曲明 N-去二甲基西布曲明(BTS54505) 中国人 药代动力学 高效液相色谱 二级质谱 sibutramine N-di-desmethyl sibutramine (BTS 54505) Chinese pharmacokinetics HPLC tandem mass spectrometry
  • 相关文献

参考文献2

  • 1I. D. Hind,J. E. Mangham,S. P. Ghani,R. E. Haddock,C. J. Garratt,R. W. Jones. Sibutramine pharmacokinetics in young and elderly healthy subjects[J] 1999,European Journal of Clinical Pharmacology(11):847~849
  • 2Graham P. Luscombe,Nigel A. Slater,Michael B. Lyons,Ronan D. Wynne,Monte L. Scheinbaum,W. Roger Buckett. Effect on radiolabelled-monoamine uptake in vitro of plasma taken from healthy volunteers administered the antidepressant sibutramine HCl[J] 1990,Psychopharmacology(3):345~349

同被引文献61

  • 1钟大放.以加权最小二乘法建立生物分析标准曲线的若干问题[J].药物分析杂志,1996,16(5):343-346. 被引量:581
  • 2李中东,施孝金,刘罡一,余琛,焦正,钟明康.西布曲明片在健康人体中的药代动力学与相对生物利用度[J].中国临床药理学杂志,2007,23(2):118-121. 被引量:3
  • 3Hind D, Mangham JE, Ghani SP, etal. Sibutramine pharmacokineties in young and elderly healthy subjects [J].J Clin Pharmacol,1999, 54(11) :847.
  • 4Luque CA, Rey JA. The discovery and status of sibutramine as an anti-obesity drug [J]. Eur J Parmacol, 2002, 440(2- 3) :119. 128.
  • 5化学药物制剂人体生物利用度和生物等效性研究技术指导原则[EB/OL].(2005-3).
  • 6Shah V'P, Midha KK, Dighe S, etal. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies[J]. J Pharm Sci, 1992,81(3) :309-312.
  • 7Noriko Koda,Yasutaka Tsutsui,Hamki Niwa,et al. Synthesis of prostaglandin F ethanolamide by prostagiArldin F synthase and identification of Bimatoprost as a potent inhibitor of the enzyme:new eazymeassay method using LC/ESI/MS. Archives of Biochemistry and Biophysics, 2004,424 (2) :128.
  • 8Virginia Carbone, Paola Montoro, Nunziatina de Tommasi, et al. Analysis of flavonoids from Cyclanthera pedata fimits by liquid chromatography/electrospray mass spectrometry. J Pharm Biomed, 2004, 34(2) :295.
  • 9Makoto Ichikawa, Kenjiro Ryu, Jiro Yoshida, et al. Identification of Six Phenylpropanoids from Garlic Skin as Major Antioxidants. J Agric Food Chem,2003,51 (25) :7313.
  • 10Vanheenacker G, De Keukeleire D, Sandra P. Analysis of iso - α -acids and reduced iso - α - acids in beer by direct injection and liquid chromatography with ultraviolet absorbance detection or with masss pectrometry. J Chromatogr A,2004,1035(1) :53.

引证文献3

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部